Back
Alimera Sciences Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
93
ALIM
Alimera Sciences
Last Price:
5.53
Seasonality Move:
-11.98%
Buy
55
ANIP
ANI Pharmaceuticals
Last Price:
61.43
Seasonality Move:
-3.21%
Buy
93
Alimera Sciences (ALIM)
is a Buy
Is Alimera Sciences a Buy, Sell or Hold?
- The current Alimera Sciences [ALIM] share price is $5.55. The Score for ALIM is 93, which is 86% above its historic median score of 50, and infers lower risk than normal.
- ALIM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
55
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.44. The Score for ANIP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALIM Stock Price Chart
What is Alimera Sciences's stock price today?
-
The Alimera Sciences share price today is $5.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALIM is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALIM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.65 | Buy |
| Relative Strength Index (14 RSI): | 82.73 | Buy |
| Chaikin Money Flow: | 282336 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.76 - 5.14) | Buy |
| Bollinger Bands (100): | (3.03 - 4.35) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 44.49 | Sell |
| Chaikin Money Flow: | 96046 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.2 - 65.78) | Sell |
| Bollinger Bands (100): | (61.21 - 67.89) | Sell |
ALIM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.53 | Buy |
| 20-day SMA: | 4.17 | Buy |
| 50-day SMA: | 3.66 | Buy |
| 200-day SMA: | 3.6 | Buy |
| 8-day EMA: | 5.28 | Buy |
| 20-day EMA: | 4.55 | Buy |
| 50-day EMA: | 3.96 | Buy |
| 200-day EMA: | 3.63 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.1 | Sell |
| 20-day SMA: | 63.18 | Sell |
| 50-day SMA: | 64.11 | Sell |
| 200-day SMA: | 60.12 | Buy |
| 8-day EMA: | 62.33 | Sell |
| 20-day EMA: | 62.89 | Sell |
| 50-day EMA: | 63.63 | Sell |
| 200-day EMA: | 60.2 | Buy |
Alimera Sciences Earnings Growth & ALIM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.04 per share, an increase this year of $0.24 per share, and an increase next year of $0.24 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.02 per share, and an increase next year of $0.72 per share.
Alimera Sciences Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||